282 related articles for article (PubMed ID: 4988692)
1. Effectiveness of live or killed plague vaccines in man.
Meyer KF
Bull World Health Organ; 1970; 42(5):653-66. PubMed ID: 4988692
[TBL] [Abstract][Full Text] [Related]
2. Recent studies on the immunity response to administration of different plague vaccines.
MEYER KF
Bull World Health Organ; 1953; 9(5):619-36. PubMed ID: 13115983
[TBL] [Abstract][Full Text] [Related]
3. Pathogenicity and immunogenic efficacy of a live attentuated plaque vaccine in vervet monkeys.
Hallett AF; Isaäcson M; Meyer KF
Infect Immun; 1973 Dec; 8(6):876-81. PubMed ID: 4206343
[TBL] [Abstract][Full Text] [Related]
4. Vaccination against bubonic and pneumonic plague.
Titball RW; Williamson ED
Vaccine; 2001 Jul; 19(30):4175-84. PubMed ID: 11457543
[TBL] [Abstract][Full Text] [Related]
5. Measuring the efficacy of vaccination in affording protection against plague.
Williams JE; Cavanaugh DC
Bull World Health Organ; 1979; 57(2):309-13. PubMed ID: 312163
[TBL] [Abstract][Full Text] [Related]
6. Immunity in plague: protection induced in Cercopithecus aethiops by oral administration of live, attenuated Yersinia pestis.
Chen TH; Elbert SS; Eisler DM
J Infect Dis; 1976 Mar; 133(3):302-9. PubMed ID: 815445
[TBL] [Abstract][Full Text] [Related]
7. Live-attenuated Yersinia pestis vaccines.
Wang X; Zhang X; Zhou D; Yang R
Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
[TBL] [Abstract][Full Text] [Related]
8. [Duration and intensity of postvaccinal immunity to plague in experimental animals].
Chicherin IuV; Evstigneev VI; Lebedinskiĭ VA
Zh Mikrobiol Epidemiol Immunobiol; 1977 May; (5):95-8. PubMed ID: 409008
[TBL] [Abstract][Full Text] [Related]
9. Potency of killed plague vaccines prepared from avirulent Yersinia pestis.
Williams JE; Altieri PL; Berman S; Lowenthal JP; Cavanaugh DC
Bull World Health Organ; 1980; 58(5):753-6. PubMed ID: 6975184
[TBL] [Abstract][Full Text] [Related]
10. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Live Plague Vaccine Candidates.
Feodorova VA; Sayapina LV; Motin VL
Methods Mol Biol; 2016; 1403():487-98. PubMed ID: 27076149
[TBL] [Abstract][Full Text] [Related]
12. Prevention of bubonic and pneumonic plague using plant-derived vaccines.
Alvarez ML; Cardineau GA
Biotechnol Adv; 2010; 28(1):184-96. PubMed ID: 19931370
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of plague vaccines in mice and guinea pigs.
von Metz E; Eisler DM; Hottle GA
Appl Microbiol; 1971 Jul; 22(1):84-8. PubMed ID: 5111306
[TBL] [Abstract][Full Text] [Related]
14. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.
Bozue J; Cote CK; Webster W; Bassett A; Tobery S; Little S; Swietnicki W
FEMS Microbiol Lett; 2012 Jul; 332(2):113-21. PubMed ID: 22537022
[TBL] [Abstract][Full Text] [Related]
15. Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270.
Qi Z; Zhou L; Zhang Q; Ren L; Dai R; Wu B; Wang T; Zhu Z; Yang Y; Cui B; Wang Z; Wang H; Qiu Y; Guo Z; Yang R; Wang X
Vaccine; 2010 Feb; 28(6):1655-60. PubMed ID: 20079562
[TBL] [Abstract][Full Text] [Related]
16. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ
Vaccine; 2009 Apr; 27(16):2220-9. PubMed ID: 19428836
[TBL] [Abstract][Full Text] [Related]
17. Vaccines for preventing plague.
Jefferson T; Demicheli V; Pratt M
Cochrane Database Syst Rev; 2000; 1998(2):CD000976. PubMed ID: 10796565
[TBL] [Abstract][Full Text] [Related]
18. Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V).
Fellows P; Adamovicz J; Hartings J; Sherwood R; Mega W; Brasel T; Barr E; Holland L; Lin W; Rom A; Blackwelder W; Price J; Morris S; Snow D; Hart MK
Vaccine; 2010 Nov; 28(49):7748-56. PubMed ID: 20920572
[TBL] [Abstract][Full Text] [Related]
19. Pneumonic plague in an untreated plague-vaccinated individual.
Cohen RJ; Stockard JL
JAMA; 1967 Oct; 202(4):365-6. PubMed ID: 6072311
[No Abstract] [Full Text] [Related]
20. [A molecular basis of the plague vaccine development].
Dentovskaia SV; Kopylov PKh; Ivanov SA; Ageev SA; Anisimov AP
Mol Gen Mikrobiol Virusol; 2013; (3):3-12. PubMed ID: 24364139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
